Suscribirse

Positive no-touch surfaces and undetectable SARS-CoV-2 aerosols in long-term care facilities: An attempt to understand the contributing factors and the importance of timing in air sampling campaigns - 25/05/21

Doi : 10.1016/j.ajic.2021.02.004 
Nathan Dumont-Leblond, MSc a, Marc Veillette, MSc a, Luc Bhérer, MD b, Karine Boissoneault, MSc b, Samira Mubareka, MD c, Lily Yip, MSc c, Marie-Eve Dubuis, MSc a, Yves Longtin, MD d, e, Philippe Jouvet, MD, PhD f, Alison McGeer, MD g, h, Caroline Duchaine, PhD a, i, j,
a Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada 
b Centre Intégré Universitaire en Santé et Services Sociaux de la Capitale-Nationale, Quebec City, QC, Canada 
c Sunnybrook Research Institute and Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada 
d Jewish General Hospital, Montreal, QC, Canada 
e Lady Davis Research Institute, Montreal, QC, Canada 
f Université de Montréal, St. Justine Hospital, Department of Pediatrics, Montreal, QC, Canada 
g Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada 
h Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada 
i Département de Biochimie, de Microbiologie et de Bio-informatique, Faculté des Sciences et de Génie, Université Laval, Quebec City, QC, Canada 
j Canada Research Chair on Bioaerosols, Quebec city, QC, Canada 

Address correspondence to Caroline Duchaine, PhD, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Chemin Ste-Foy, Quebec City, QC, Canada G1V 4G5.Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec2725 Chemin Ste-FoyQuebec CityQCG1V 4G5Canada

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Around 32% of no-touch surfaces were positive for SARS-CoV-2 in long-term carefacilities.
Undetectable airborne SARS-CoV-2, 8-30 days after residents’ symptoms onset.
Reconsideration of exposure risks in LTCFs is necessary.
Timing is crucial in air sampling campaign deployment.
Collaboration of LTCFs is key to study and have quick access to COVID-19 outbreaks.

El texto completo de este artículo está disponible en PDF.

Resumen

Background

Long-term care facilities (LTCF) are environments particularly favorable to coronavirus disease (SARS-CoV-2) pandemic outbreaks, due to the at-risk population they welcome and the close proximity of residents. Yet, the transmission dynamics of the disease in these establishments remain unclear.

Methods

Air and no-touch surfaces of 31 rooms from 7 LTCFs were sampled and SARS-CoV-2 was quantified by real-time reverse transcription polymerase chain reaction (RT-qPCR).

Results

Air samples were negative but viral genomes were recovered from 20 of 62 surface samples at concentrations ranging from 13 to 36,612 genomes/surface. Virus isolation (culture) from surface samples (n = 7) was negative.

Conclusions

The presence of viral RNA on no-touch surfaces is evidence of viral dissemination through air, but the lack of airborne viral particles in air samples suggests that they were not aerosolized in a significant manner during air sampling sessions. The air samples were collected 8 to 30 days after the residents’ symptom onset, which could indicate that viruses are aerosolized early in the infection process. Additional research is needed to evaluate viral viability conservation and the potential role of direct contact and aerosols in SARS-CoV-2 transmission in these institutions.

El texto completo de este artículo está disponible en PDF.

KEY WORDS : COVID-19, Bioaerosols


Esquema


 Conflicts of interest: The authors have no conflict of interest to disclose.
 Funding: This work was supported by the Fonds de recherche du Québec -Santé (COVID-19 Pandemic Initiative funds), the Institut de Recherche Robert-Sauvé en Santé et en Sécurité du Travail du Québec (IRSST 2017-0004), Toronto COVID-19 Action Initiative (University of Toronto) and Questcap Inc. Sponsors had no direct role in the design of the study or the publishing process. CD is the holder of Tier-1 Canada Research Chair on Bioaerosols.


© 2021  Association for Professionals in Infection Control and Epidemiology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 49 - N° 6

P. 701-706 - juin 2021 Regresar al número
Artículo precedente Artículo precedente
  • Impact of the influenza vaccine on COVID-19 infection rates and severity
  • Anna Conlon, Carmel Ashur, Laraine Washer, Kim A. Eagle, Marion A. Hofmann Bowman
| Artículo siguiente Artículo siguiente
  • Microbial contamination of powered air purifying respirators (PAPR) used by healthcare staff during the COVID-19 pandemic: an in situ microbiological study
  • Abhijoy Chakladar, Claire G. Jones, Jimmy Siu, Mohammed Osman Hassan-Ibrahim, Mansoor Khan

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.